Royal Philips, a global leader in health technology, has announced an expanded collaboration with Cortechs.ai, a pioneer in quantitative neuroimaging analytics. Through this enhanced partnership, Cortechs.ai’s advanced AI-enabled neuroimaging tools will be integrated directly into Philips’ MR systems, giving clinicians faster, more objective, and reproducible insights into brain health. The joint effort strengthens Philips’ growing leadership in precision neuro diagnostics by combining its next-generation MR technologies with Cortechs.ai’s AI-driven post-processing solutions.
Advancing Smart, Standardized Brain Imaging
Brain examinations account for nearly a quarter of all MR procedures, placing significant pressure on radiology departments already challenged by rising demand and workforce shortages. With neurological conditions—such as Alzheimer’s disease, multiple sclerosis (MS), and brain tumors—continuing to increase globally, the reliance on visual interpretation adds variability and requires high levels of expertise.
The extended partnership aims to deliver data-driven, standardized neuroimaging by embedding quantitative tools like brain volumetrics, lesion quantification, and tumor tracking directly into the Philips MR workflow. Clinicians gain access to objective, numerical biomarkers alongside imaging data, supporting faster and more consistent diagnostic decision-making.
Precision and Speed Through Seamless Integration
Cortechs.ai’s NeuroQuant® solutions for Alzheimer’s, MS, and neuro-oncology will now be incorporated into Philips’ Smart Reading environment—a cloud-based AI platform enabling integrated imaging, reading, and reporting on MR systems.
This integration enables clinicians to automatically receive AI-generated quantitative reports within their routine MR or PACS workflow, without adding steps for technologists. The zero-click, automated process ensures standardized, quality-checked outputs, reducing variability and accelerating interpretation.
“This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions.”
— Ioannis Panagiotelis, PhD, Business Leader, MRI, Philips
Boosting Productivity and Enhancing Patient Care Through AI
Philips continues to drive efficiency and diagnostic quality through deep AI integration across its imaging ecosystem. Automated quantitative reporting improves consistency, saves radiologists significant time, and increases department throughput. Objective biomarkers enable more reproducible assessments and clearer comparisons across visits and care sites. By removing manual post-processing steps, technologists can focus more on patient interaction and experience.
“Cortechs.ai’s mission has always been to empower clinicians with actionable, quantitative insights,” said Kyle Frye, Chief Executive Officer, Cortechs.ai. “By combining our advanced neuro analytics with Philips’ leading MR platform and AI infrastructure, we’re making it easier to personalize brain care and track neurological changes with precision.”
Setting a New Benchmark in Precision Neuro Diagnostics
Cortechs.ai’s NeuroQuant® suite is already available via Philips’ Advanced Visualization Workspace. The expanded collaboration underscores Philips’ commitment to advancing neurological care through scalable, AI-powered innovation—helping clinicians deliver faster, more accurate, and more confident diagnoses for an increasing number of patients.
Also Read